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SIK2 regulates CRTCs, HDAC4 and glucose uptake in adipocytes
Emma Henriksson1,*, Johanna Sa¨ll1, Ame´lie Gormand1, Sebastian Wasserstrom2, Nicholas A. Morrice3,`,
Andreas M. Fritzen4, Marc Foretz5, David G. Campbell6, Kei Sakamoto6,§, Mikael Ekelund7, Eva Degerman8,
Karin G. Stenkula2 and Olga Go¨ransson1,"
ABSTRACT
Salt-inducible kinase 2 (SIK2) is an AMP-activated protein
kinase (AMPK) related kinase abundantly expressed in adipose
tissue. Our aim was to identify molecular targets and functions of
SIK2 in adipocytes, and to address the role of PKA-mediated
phosphorylation of SIK2 on Ser358. Modulation of SIK2 in adipocytes
resulted in altered phosphorylation of CREB-regulated transcription
co-activator 2 (CRTC2), CRTC3 and class IIa histone deacetylase
4 (HDAC4). Furthermore, CRTC2, CRTC3, HDAC4 and protein
phosphatase 2A (PP2A) interacted with SIK2, and the binding of
CRTCs and PP2A to wild-type but not Ser358Ala SIK2, was reduced
by cAMP elevation. Silencing of SIK2 resulted in reduced GLUT4
(also known as SLC2A4) protein levels, whereas cells treated with
CRTC2 or HDAC4 siRNA displayed increased levels of GLUT4.
Overexpression or pharmacological inhibition of SIK2 resulted in
increased and decreased glucose uptake, respectively. We also
describe a SIK2–CRTC2–HDAC4 pathway and its regulation in
human adipocytes, strengthening the physiological relevance of our
findings. Collectively, we demonstrate that SIK2 acts directly on
CRTC2, CRTC3 and HDAC4, and that the cAMP–PKA pathway
reduces the interaction of SIK2 with CRTCs and PP2A. Downstream,
SIK2 increases GLUT4 levels and glucose uptake in adipocytes.
KEY WORDS: SIK2, Adipocyte, CRTC2, CRTC3, HDAC4, PP2A,
Glucose uptake
INTRODUCTION
The AMPK-related kinase salt-inducible kinase 2 (SIK2) is
abundantly expressed in adipocytes and both protein and activity
levels have been found to be increased in an obese mouse model
(Du et al., 2008; Horike et al., 2003). In spite of this, no substrates
of SIK2 have so far been described in adipocytes. The kinase
activity of SIK2, similar to AMPK and other AMPK-related
kinases, is dependent on its phosphorylation at Thr175 by the
upstream kinase LKB1 (also known as STK11) (Lizcano et al.,
2004). SIK2 is also phosphorylated at other sites and this might
further control its cellular function (Dentin et al., 2007; Katoh
et al., 2004; Sasaki et al., 2011). In adipocytes, we recently
demonstrated that SIK2 is regulated by the cAMP–PKA pathway
through phosphorylation of Ser358, resulting in the binding of
SIK2 to 14-3-3 proteins and a subsequent relocalisation to the
cytosol with no effect on intrinsic kinase activity (Henriksson
et al., 2012). Insulin, which has been suggested to regulate SIK2
activity and Ser358 phosphorylation (Dentin et al., 2007; Ku¨ser-
Abali et al., 2013), was found not to alter SIK2 Ser358
phosphorylation or activity in adipocytes (Henriksson et al.,
2012). In HEK293T cells, SIK2 has also been reported to be
regulated by its binding to protein phosphatase 2A (PP2A), which
acts to preserve SIK2 kinase activity (Lee et al., 2014).
In contrast to AMPK, the targets of which include many
metabolic enzymes (Hardie et al., 2012), SIK isoforms have so
far mainly been suggested to regulate gene expression by
phosphorylating transcriptional regulators like the CREB-
regulated transcription co-activators (CRTCs) (Dentin et al.,
2007; Horike et al., 2010; Koo et al., 2005; Patel et al., 2014;
Screaton et al., 2004). This regulation has been described in non-
adipose cells, including pancreatic beta cells, melanocytes and
hepatocytes. CRTCs, when phosphorylated, bind to 14-3-3 proteins
and are sequestered in the cytoplasm where they are unable to
activate CREB-induced gene transcription (Bittinger et al., 2004;
Jansson et al., 2008; Screaton et al., 2004). In response to
elevations in cAMP, CRTCs are dephosphorylated, leading to
nuclear translocation and binding to CREB (Altarejos and
Montminy, 2011). Several sites have been described to take part
in the phosphorylation-dependent nucleo-cytoplasmic shuttling of
CRTCs. Ser171 and Ser307 have been demonstrated to regulate
CRTC2 in hepatocytes (Koo et al., 2005; Screaton et al., 2004;
Uebi et al., 2010), and phosphorylation of Ser275 by the AMPK-
related kinase MARK2 was found to be important for the exclusion
of CRTC2 from the nucleus in beta cells (Jansson et al., 2008).
Through activation of CREB target genes, CRTCs have been
linked to several important metabolic processes such as
gluconeogenesis (Dentin et al., 2007; Koo et al., 2005; Wang
et al., 2010), mitochondrial biogenesis (Than et al., 2011; Wu et al.,
2006) and beta cell survival (Jansson et al., 2008). In adipocytes,
CRTCs and CREB have been suggested to attenuate b-adrenergic
signalling as well as the expression of adiponectin and GLUT4
(also known as SLC2A4) (Qi et al., 2009; Song et al., 2010).
Similar to CRTCs, the localisation and activity of class IIa
histone deacetylases (HDACs) are also regulated by phosphorylation
and interaction with 14-3-3 proteins (Bassel-Duby and Olson,
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2006). Following their dephosphorylation, class IIa HDACs
translocate to the nucleus, where they modulate gene expression
by associating with transcription factors. Class IIa HDACs are
implicated in a wide array of biological processes, including the
control of GLUT4 expression during adipogenesis and the activity
of FOXO transcription factors (Mihaylova et al., 2011; Weems and
Olson, 2011). Interestingly, they are suggested to be targets for
AMPK or SIK phosphorylation in Drosophila, Caenorhabditis
elegans and in mammals (Berdeaux et al., 2007; van der Linden
et al., 2007; Walkinshaw et al., 2013; Wang et al., 2011). In
Drosophila, the regulation of HDAC4 by a SIK isoform is
important for lipid accumulation in response to feeding and
starvation (Wang et al., 2011).
Although it is not mechanistically clear how, cAMP–PKA-
mediated phosphorylation of SIKs has been suggested to inhibit SIK
function, leading to CRTC and class IIa HDAC dephosphorylation
and activation (Screaton et al., 2004; Takemori and Okamoto,
2008). In adipocytes, the cAMP-induced binding to 14-3-3 proteins
and relocalisation of SIK2 that we described previously (Henriksson
et al., 2012) could potentially restrict the ability of SIK2 to
phosphorylate its substrates. This view is supported by our recent
findings in hepatocytes, in which we demonstrated that SIK2, like in
adipocytes, is subject to multi-site phosphorylation in response to
cAMP induction, and that overexpression of a phosphorylation-
resistant version of SIK2 prevented cAMP-induced reduction in the
phosphorylation of CRTC2 (Patel et al., 2014). The identity of
substrates and thus the biological function of SIK2 in adipocytes,
however, remain to be investigated. In this study, we present
evidence that CRTC2, CRTC3 and HDAC4 are direct molecular
targets of SIK2 in both rodent and human adipocytes. Using these
proteins as read-outs of SIK2 cellular activity, we also evaluate the
functional importance of cAMP-mediated regulation of SIK2 in
these cells. Moreover, we demonstrate that SIK2 is involved in the
regulation of GLUT4 levels and glucose uptake in adipocytes,
potentially through its action on CRTCs and HDAC4.
RESULTS
Phosphorylation of CRTC2 and class IIa HDACs is reduced
following LKB1 silencing in adipocytes
When silencing the expression of LKB1 in 3T3-L1 adipocytes
using retrovirally introduced short hairpin RNA (shRNA), we
observed that the phosphorylation of CRTC2 at Ser275, a site
known to regulate the localisation of CRTC2 (Jansson et al.,
2008), was significantly reduced (Fig. 1A, left panel). The
multiple bands detected in these cells using the Ser275-specific
antibody most likely represent other similarly regulated CRTC
isoforms. We also monitored the phosphorylation of class IIa
HDACs 4, 5 and 7 at Ser246, Ser259 and Ser155, respectively,
and similarly to CRTC2, the phosphorylation of class IIa HDACs
was reduced in LKB1-shRNA-treated adipocytes (Fig. 1A, right
panel). Based on its clear responsiveness to cAMP (Figs 2–4),
along with recent findings suggesting that HDAC4 is of particular
relevance in mature adipocytes (Weems et al., 2012), we focused
on this class IIa HDAC isoform in our further analysis. Only low
amounts of residual LKB1 protein and mRNA expression were
detected in adipocytes expressing LKB1 shRNA, as shown by
western blotting and qPCR (Fig. 1B). The LKB1 antibody detects
a doublet, out of which the lower band is absent in LKB1-
shRNA-expressing cells and hence represents LKB1. The upper
band represents a nonspecific target of the antibody.
Fig. 1. LKB1-shRNA-expressing
adipocytes display reduced
phosphorylation of CRTC2 and HDAC4.
(A, B) 3T3-L1 preadipocytes were
lentivirally transduced with scrambled (Scr)
or LKB1 shRNA and differentiated into
adipocytes. Lysates from fully differentiated
cells were analysed with antibodies against
Ser275 phosphorylation of CRTC2
(A, left) and Ser246, Ser259 and Ser155
phosphorylation of class IIa HDAC4,
HDAC5 and HDAC7, respectively
(A, right). The bar graphs represent
quantified phosphorylation western blot
signals, corrected for total protein levels
(CRTC2 and HDAC4). The triplicates
shown in the western blots constitute three
independent experiments. (B) LKB1 levels
in LKB1-shRNA-expressing cells were
compared to those of Scr-treated control
cells by western blotting (B, left) and qPCR
analysis (B, right). ERK1/2 was used as a
loading control. The data are presented as
the mean6s.e.m. (two to five individual
experiments); **P,0.01; ***P,0.001.
RESEARCH ARTICLE Journal of Cell Science (2015) 128, 472–486 doi:10.1242/jcs.153932
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was reduced by electroporation of scrambled (Scr) or SIK2 siRNA into differentiated 3T3-L1 adipocytes. The effect of SIK2 silencing for 48 h (A) or 72 h
(B–D) on the phosphorylation of potential molecular targets was monitored by investigating CRTC2 and CRTC3 electrophoretic mobility shifts (A) and by using
phosphospecific antibodies against Ser275 of CRTC2 (B), Ser162 of CRTC3 (C) or Ser246 of HDAC4 (D). Bar graphs represent the mean6s.e.m. of quantified
western blot signals from two to four individual experiments in which the data were normalized to those of Scr-treated non-stimulated cells (set as 100%).
(E–G) Primary rat adipocytes were treated with increasing doses of HG-9-91-01 for 1 h and the phosphorylation of CRTC2 and HDAC4 was analysed by
western blotting using phosphospecific antibodies against Ser275 of CRTC2 (E) or Ser246 of HDAC4 (F), or by monitoring the electrophoretic mobility of CRTC3
(G). In E, western blotting was performed on CRTC2 immunoprecipitates. Bar graphs represent the mean6s.e.m. of quantified western blot signals from three or
four individual experiments in which the data were normalized to those of non-treated cells (set as 100%). *P,0.05.
RESEARCH ARTICLE Journal of Cell Science (2015) 128, 472–486 doi:10.1242/jcs.153932
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Endogenous SIK2 is required for the phosphorylation of
CRTC2, CRTC3 and HDAC4 in adipocytes
Our findings in LKB1-shRNA-expressing cells demonstrated
that the phosphorylation of CRTC2 and HDAC4 is regulated
downstream of LKB1 in adipocytes. Effects of LKB1, including
those on CRTC isoforms and class IIa HDACs, have been shown
previously to be mediated by members of the AMPK family of
kinases, which require LKB1 for their activity (Lizcano et al.,
2004). Therefore, we next investigated the requirement for SIK2,
one of the most prominently expressed AMPK-related kinases in
adipocytes, in the phosphorylation of CRTC2 and HDAC4 in
these cells. We also analysed the phosphorylation of CRTC3,
another CRTC family member that has been reported to attenuate
cAMP signalling in adipose tissue (Song et al., 2010). For this
purpose, 3T3-L1 adipocytes were electroporated with scrambled
(Scr) small interfering RNA (siRNA) or siRNA targeting SIK2,
and the phosphorylation of CRTC2, CRTC3 and HDAC4 was
monitored in response to elevated levels of cAMP following
stimulation of the cells with the b3-adrenergic receptor agonist
CL 316,243 (Fig. 2A–D). The kinase activity of SIK2 in
adipocytes treated with SIK2 siRNA was 25% of that in Scr-
treated cells, and SIK2 protein levels were similarly reduced
(supplementary material Fig. S1). The mRNA level of SIK2 was
found to be 45% of that in Scr-treated cells 72 h after
Fig. 3. Adenoviral expression of SIK2 results in
increased phosphorylation of CRTC2, CRTC3 and
HDAC4 in adipocytes – the role of SIK2 kinase
activity. Primary rat adipocytes were transduced
overnight with adenoviral vectors encoding GFP or
wild-type (wt) or Thr175Ala SIK2, and then treated with
CL 316,243 (100 nM, 30 min). The effect on CRTC2
(A,B,E), CRTC3 (C,D) and HDAC4 (F) phosphorylation
was evaluated by monitoring their migration pattern on
SDS-PAGE gels (A–D) or by western blotting using
phosphospecific antibodies against Ser275 of CRTC2
(E) and Ser246 of HDAC4 (F). Bar graphs represent
the mean6s.e.m. of quantified western blot signals
from three individual experiments in which the data
were normalized to those of non-treated cells
expressing wild-type SIK2 (set as 100%). *P,0.05.
RESEARCH ARTICLE Journal of Cell Science (2015) 128, 472–486 doi:10.1242/jcs.153932
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electroporation (data not shown). No changes in mRNA or
protein expression of AMPK and SIK3, or in the activity of
AMPK (as evaluated using phosphospecific antibodies against
Thr172), were detected as a result of reduced expression and
activity of SIK2 (data not shown). Phosphorylation of hormone-
sensitive lipase (HSL) on Ser563 was used as a positive control
for the successful induction of cAMP–PKA throughout this paper.
Both CRTC2 and CRTC3 displayed a reduction in overall
phosphorylation after silencing of SIK2 for 48 h or 72 h, as
demonstrated by a slightly faster migration in 7% SDS-PAGE
detected by western blotting (Fig. 2A). This effect was more
prominent after 72 h of SIK2 silencing, and this time-point
was thus selected for additional experiments. The specific
phosphorylation of CRTC2 at Ser275 was clearly reduced in
Fig. 4. Role of PKA phosphorylation sites in SIK2
for the regulation of CRTC2 and HDAC4
dephosphorylation by cAMP. (A) Adenoviral vectors
encoding wild-type (wt), Ser343Ala, Ser358Ala,
Thr484Ala or Ser587Ala SIK2 were introduced into
primary adipocytes followed by treatment with CL
316,243 (100 nM, 30 min). The phosphorylation of
SIK2 was analysed by western blotting using PKA
consensus antibodies (PKA cons), anti-SIK2-pSer358
or anti-SIK2-pSer343 antibodies (upper panel). HA
immunoprecipitates (IP) of SIK2 were analysed for the
presence of 14-3-3 proteins (lower panel). Similar
results were obtained in two individual experiments.
(B,C) Adenoviral vectors encoding wild-type or
Ser358Ala SIK2 were introduced into primary
adipocytes, followed by stimulation of the cells as in A.
The phosphorylation of CRTC2 on Ser275 (B) or
HDAC4 on Ser246 (C) was analysed by western
blotting using phosphospecific antibodies. Bar graphs
represent the mean6s.e.m. of quantified western blot
signals from four to six individual experiments in which
the data were normalized to those of non-treated cells
for each construct (set as 100%). *P,0.05;
**P,0.01; ***P,0.001.
RESEARCH ARTICLE Journal of Cell Science (2015) 128, 472–486 doi:10.1242/jcs.153932
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response to increased levels of cAMP in adipocytes, and was also
significantly lower in SIK2-siRNA-treated cells as compared with
the Scr control (Fig. 2B). Dephosphorylation after cAMP
induction or SIK2 siRNA treatment was also observed when
analysing the phosphorylation of CRTC3 on Ser162 (Fig. 2C), a
site shown to be phosphorylated by SIK isoforms and to control
CRTC3 function in macrophages (Clark et al., 2012). The
antibody against phosphorylated (p)CRTC3-Ser162 detects two
bands, out of which (as determined in immunoprecipitation
experiments) the upper one represents phosphorylation of CRTC2
on Ser171 and the lower band represents phosphorylation of
CRTC3. Furthermore, as shown in Fig. 2D, phosphorylation of
HDAC4 on Ser246 was significantly reduced in cells treated
with the b3-adrenergic receptor agonist or with SIK2 siRNA.
In conclusion, silencing of SIK2 resulted in a reduction of
overall as well as site-specific phosphorylation of CRTC2,
CRTC3 and HDAC4 in adipocytes. The specific phosphorylations
investigated were in all cases reduced to the same level as in
CL 316,243-treated Scr-siRNA-expressing cells, indicating an
important role of endogenous SIK2 in maintaining CRTC and
HDAC4 phosphorylation in resting cells.
Given that silencing by means of siRNA is not possible in
primary adipocytes, we instead used the highly selective pan-SIK
inhibitor HG-9-91-01 (Clark et al., 2012) to address the
requirement for SIK2 in the phosphorylation of CRTC2,
CRTC3 and HDAC4 in this more physiologically relevant
model. Treatment of primary rat adipocytes with HG-9-91-01
for 1 h resulted in a dose-dependent reduction in the
phosphorylation of CRTC2 and HDAC4 on Ser275 and Ser246,
respectively (Fig. 2E,F). The antibody against pCRTC3-Ser162
was not sensitive enough to allow us to confidently detect specific
phosphorylation of CRTC3 in primary cells, but a downward shift
in the electrophoretic mobility of CRTC3 indicated that HG-9-91-
01 induced a dephosphorylation of this CRTC isoform as well
(Fig. 2G). These data further support a role for SIK2 in the
regulation of CRTCs and HDAC4 in adipocytes, and confirm the
efficacy of HG-9-91-01 in these cells.
Overexpression of SIK2 is sufficient to induce
phosphorylation of CRTCs and HDAC4 in primary adipocytes
We next employed adenoviral overexpression of HA–SIK2 in
primary rat adipocytes to study whether increased SIK2 levels are
sufficient to induce CRTC and HDAC4 phosphorylation, as well
as the requirement of SIK2 kinase activity for this effect. Primary
rat adipocytes were transduced overnight with adenoviral vectors
encoding GFP, wild-type SIK2 or a kinase-inactive version of
SIK2, in which the T-loop Thr175 residue has been converted to
alanine (Thr175Ala SIK2). As observed in 3T3-L1 adipocytes,
both CRTC2 and CRTC3 were dephosphorylated in response to
cAMP elevation in primary adipocytes, as indicated by an
electrophoretic mobility gel shift downwards in response to
stimulation with CL 316,243 (Fig. 3A,C). Expression of wild-
type SIK2, but not the Thr175Ala mutant, resulted in a slower
migration of CRTC2 and CRTC3 compared with that of the
GFP control (Fig. 3B,D), indicating an increased overall
phosphorylation status. The phosphorylation of CRTC2 on
Ser275 was reduced in response to CL 316,243 (Fig. 3E), and
the basal phosphorylation of this site was robustly increased
in cells expressing wild-type SIK2 compared with those
expressing Thr175Ala SIK2 or GFP (Fig. 3E). Similarly, the
phosphorylation of HDAC4 on Ser246 was increased after
expression of wild-type SIK2 (Fig. 3F). The ability of wild-type
but not kinase-inactive SIK2 to promote the phosphorylation
of CRTC2, CRTC3 and HDAC4 further supports a role for SIK2
in the phosphorylation of these transcriptional regulators and
demonstrates that SIK2 activity is required for this process.
Role of PKA-mediated phosphorylation of SIK2 for the
regulation of CRTCs and HDAC4 by cAMP in adipocytes
SIK2 is regulated by cAMP–PKA signalling in adipocytes
through phosphorylation at four sites – Ser343, Ser358, Thr484
and Ser587 – and we have shown previously that this is
associated with the binding of SIK2 to 14-3-3 proteins
(Henriksson et al., 2012). The total phosphorylation of SIK2 by
PKA after CL 316,243-treatment, as measured by the use of PKA
consensus antibodies and the binding of 14-3-3, was dramatically
reduced when expressing Ser343Ala- or Ser358Ala SIK2 in
primary rat adipocytes, but not when mutating Thr484 or Ser587
(Fig. 4A). From blotting with anti-pSer358 or anti-pSer343
antibodies, but also from phosphopeptide mapping performed
previously by us (Henriksson et al., 2012), it was clear that the
Ser343Ala mutant lacks phosphorylation on both Ser343 and
Ser358, whereas the Ser358Ala mutant is still phosphorylated on
Ser343. From these data, we conclude that Ser358 appears to be
the dominant site in SIK2 mediating its regulation by cAMP–
PKA in adipocytes. We therefore focused on Ser358 in our
investigation of whether PKA phosphorylation of SIK2 is
functionally important for the regulation of CRTC2 and
HDAC4 by cAMP. Wild-type or Ser358Ala SIK2 were
expressed in primary adipocytes, which were then stimulated
with CL 316,243 to increase cAMP levels. As previously
observed, the phosphorylation of CRTC2 and HDAC4 was
reduced in response to increased levels of cAMP in cells
expressing wild-type SIK2 (Fig. 3; Fig. 4B,C). Contrary to our
expectation, this cAMP-induced dephosphorylation was not
affected when expressing the Ser358Ala mutant SIK2
(Fig. 4B,C). This suggests that PKA phosphorylation of SIK2
on Ser358 does not alone mediate the cAMP-induced
dephosphorylation of CRTC2 and HDAC4.
CRTC2, CRTC3, HDAC4 and PP2A interact with SIK2 in
primary adipocytes
To identify SIK2-interacting proteins, we employed both focused
and more general unbiased strategies. First, to address whether
CRTC2, CRTC3 and HDAC4 are indeed direct molecular targets
of SIK2 in adipocytes, as well as to further evaluate the functional
importance of SIK2 Ser358 phosphorylation, we specifically
investigated the ability of CRTC2, CRTC3 and HDAC4 to
interact with different variants of SIK2 and the effect of cAMP on
these interactions. HA-tagged wild-type or Ser358Ala SIK2 were
expressed in primary adipocytes followed by stimulation with CL
316,243. HA–SIK2 was then immunoisolated using anti-HA–
agarose, and co-immunoprecipitating proteins were identified by
western blotting. Lysates from GFP-expressing cells were used as
a negative control. As shown previously (Henriksson et al., 2012;
Fig. 4A), CL 316,243 induced the binding of wild-type but not
Ser358Ala SIK2 to 14-3-3 proteins (Fig. 5A–C). CRTC2, CRTC3
and HDAC4 all co-immunoprecipitated with both the wild-type
and the mutated version of SIK2 (Fig. 5A–C). The interaction of
wild-type SIK2 with CRTC2 and CRTC3 decreased in response
to increased cAMP levels. This was not observed when analysing
the binding of HDAC4 to SIK2, which remained unchanged in
the presence of CL 316,243. Interestingly, the interaction of
Ser358Ala SIK2 with CRTC2 and CRTC3 was not sensitive to
RESEARCH ARTICLE Journal of Cell Science (2015) 128, 472–486 doi:10.1242/jcs.153932
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cAMP induction, as was the case for wild-type SIK2 (Fig. 5A,B).
This suggests that phosphorylation of Ser358 is important for
cAMP-dependent regulation of the interaction of SIK2 with some
of its molecular targets.
As part of a more unbiased strategy to identify SIK2 targets or
regulatory proteins, we stably expressed FLAG–SIK2 in HEK293
cells, from which large-scale immunoisolation of SIK2 was then
performed. When identifying co-immunoprecipitated proteins
by mass fingerprinting, we noted a large number of peptides
originating from the regulatory as well as the catalytic subunit of
PP2A (supplementary material Fig. S2). Immunoprecipitates of
both wild-type and Ser358Ala SIK2 contained PP2A and, in this
setting (using a non-quantitative form of mass spectrometry), we
did not observe any marked differences between samples
originating from cells stimulated with or without forskolin.
Interestingly, HA–SIK2 expressed in primary adipocytes was also
associated with different subunits of PP2A, and in these cells the
amount of the PP2A regulatory subunits A and B, and PP2A
catalytic subunits in the immunoprecipitate was clearly reduced
in response to cAMP elevation by CL 316,243 (Fig. 5D–F).
SIK2 signalling regulates GLUT4 expression and glucose
uptake in adipocytes
CREB and HDAC4 have been suggested to inhibit GLUT4
mRNA expression in adipocytes (Qi et al., 2009; Weems et al.,
2012). Therefore, we silenced SIK2, CRTC2 or HDAC4 in 3T3-
L1 adipocytes (supplementary material Fig. S3A–C) and analysed
the expression of GLUT4 protein by western blotting. Cells
treated with SIK2 siRNA displayed a 40–50% reduction in
GLUT4 protein levels (and a 30% reduction in GLUT4 mRNA
level; data not shown) compared with levels in Scr-siRNA-
transfected cells (Fig. 6A). By contrast, silencing of CRTC2 or
HDAC4 resulted in a 30–50% increase in GLUT4 protein
expression (Fig. 6B,C). Moreover, adipocytes isolated from SIK2
whole-body-knockout mice displayed a 60% reduction in GLUT4
protein levels (Fig. 6D). These data indicate that GLUT4 levels
are positively regulated by SIK2, possibly through its effects on
CRTC2 and HDAC4. Considering the important role of GLUT4
in glucose uptake, we next investigated the impact of SIK2 on
basal and insulin-stimulated glucose uptake in primary rat
adipocytes by monitoring the uptake of 14C glucose in cells
expressing GFP or the wild-type or kinase-inactive Thr175Ala
SIK2. Adipocytes expressing wild-type SIK2 displayed increased
basal glucose uptake compared with that of adipocytes expressing
GFP or Thr175Ala SIK2 (Fig. 6E). Glucose uptake in the
presence of insulin was not affected by the expression of wild-
type SIK2. However, the level of insulin-induced glucose uptake
in adipocytes expressing the inactive Thr175Ala HA–SIK2 was
found to be significantly lower compared with that of cells
expressing GFP or wild-type SIK2, raising the possibility that
Thr175Ala SIK2 acts in a dominant-negative manner. The in vitro
kinase activity of SIK2 immunoprecipitated from Thr175Ala
SIK2-expressing cells was, however, not reduced compared with
that of GFP-expressing cells (data not shown), nor was the
phosphorylation of downstream targets CRTC2 and HDAC4
(Fig. 3E, F), arguing against this idea.
We also pre-treated rat adipocytes with increasing
concentrations of HG-9-91-01, a highly selective pan-SIK
inhibitor, or MRT199665, an inhibitor of several AMPK-related
kinases including SIKs, albeit with lower potency (Clark et al.,
2012), for 16 h (to allow for changes in gene expression). We
thereafter analysed glucose uptake in the absence and presence of
insulin. As shown in Fig. 6F,G, basal and insulin-stimulated
glucose uptake were inhibited by 40–50% as a result of pre-
treatment with 1 mM HG-9-91-01. The fold-increase in glucose
uptake in response to insulin stimulation was, however, not
different in inhibitor-treated cells (Fig. 6H). Pre-treatment with
MRT199665 at slightly higher concentrations than that of HG-9-
91-01 resulted in a similar inhibition of basal glucose uptake
(Fig. 6I) (and uptake in the presence of insulin; data not shown).
These data collectively suggest that SIK2 activity is involved in
maintaining basal glucose uptake in primary rat adipocytes.
SIK2 signalling in human adipocytes
Our data from rodent adipocytes make SIK2 an interesting
protein to study in relation to human adipose tissue function and
dysfunction. Because there are no previous studies of SIK2 in
humans, we decided as a first step to address the existence of
SIK–CRTC2–HDAC4 signalling and its potential regulation in
response to cAMP–PKA activation in human adipocytes. To do
so, we used human adipocytes isolated from surgical adipose
tissue biopsies. Similar to rat adipocytes, stimulation of human
adipocytes with the b-adrenergic receptor agonist isoprenaline
resulted in the phosphorylation of SIK2 on residues Ser343,
Ser358 and Thr484, without altering the specific kinase activity
(Fig. 7A–D). Moreover, the phosphorylation of CRTC2 and
HDAC4 was significantly lower in isoprenaline- or HG-9-91-01-
treated cells compared with that of the control (Fig. 7E–H).
DISCUSSION
So far very few studies have attempted to identify molecular
targets or biological roles of SIK2 in adipocytes – even though
SIK2 levels are several-fold higher in adipose tissue than in
any other tissue. Here, we demonstrate that the transcriptional
regulators CRTC2, CRTC3 and HDAC4 are direct substrates of
SIK2 in adipocytes. Importantly, we also show the existence
of a SIK–CRTC2–HDAC4 pathway and its regulation by
physiologically relevant stimuli in human adipose tissue. This
highlights a potential role for SIK2 in human adipose tissue
function and in the development of obesity and associated
disorders. Furthermore, we show that phosphorylation of SIK2 by
PKA is required for some aspects of the regulation of CRTCs by
cAMP – a subject that has so far been poorly understood. We also
reveal a link between SIK2 signalling and the regulation of
GLUT4 levels and glucose uptake in adipocytes.
Having established that CRTCs and HDAC4 are regulated
downstream of LKB1 in adipocytes, we employed different
strategies to test the hypothesis that SIK2, at least in part,
mediates this regulation. Silencing, acute pharmacological
inhibition and overexpression experiments performed in
primary or cultured adipocytes supported the notion that
CRTC2, CRTC3 and HDAC4 are phosphorylated downstream
of SIK2. We conclude that CRTC2, CRTC3 and HDAC4 are
most likely direct substrates of SIK2 in adipocytes, based on the
following: (1) CRTCs and class IIa HDACs are phosphorylated
by SIK isoforms in vitro (Henriksson et al., 2012), (2) the sites we
found to be regulated conform to a previously described SIK2
consensus sequence (LXBS/TXSXXXL) (Screaton et al., 2004),
and (3) SIK2 interacts physically with CRTC2, CRTC3 and
HDAC4 in adipocytes (Fig. 5).
To monitor site-specific phosphorylation of CRTC2 and
CRTC3, we employed phosphospecific antibodies against
Ser275 and Ser162, respectively, both of which are sites
previously suggested to be important for the localisation of
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Fig. 5. CRTC2, CRTC3, HDAC4 and PP2A interact with SIK2 in adipocytes. Adenoviral vectors encoding GFP or wild-type (wt) or Ser358Ala SIK2 were
introduced into primary rat adipocytes, followed by treatment with CL 316,243 (100 nM, 30 min) and immunoprecipitation (IP) of HA-tagged SIK2. Co-
immunoprecipitating proteins were detected by western blotting using antibodies against CRTC2 (A), CRTC3 (B), HDAC4 (C), 14-3-3 proteins (A–D), PP2A
regulatory (reg) subunits A (PR65) (D) and B (PR55) (E), and PP2A catalytic (cat) subunit (F). Bar graphs represent the mean6s.e.m. of quantified western blot
signals from three to seven individual experiments in which the data were normalized to those of non-treated cells for each construct (set as 100%). *P,0.05;
**P,0.01; ***P,0.001.
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these proteins (Clark et al., 2012; Jansson et al., 2008; Screaton
et al., 2004). Ser275 was shown to be regulated by glucose in beta
cells, where it is phosphorylated by the AMPK-related kinase
MARK2 and mediates the binding of CRTC2 to 14-3-3 proteins
under basal conditions (Jansson et al., 2008). Interestingly, in
adipocytes, we found that this site is also a target of regulation by
cAMP and SIK2. The shift in electrophoretic mobility that we
observed (for example, when overexpressing wild-type SIK2)
indicates an effect of SIK2 on overall phosphorylation of CRTC2
and CRTC3 (and not only on Ser275 and Ser162, respectively). In
Fig. 6. SIK2–CRTC2–HDAC4 signalling
regulates GLUT4 protein levels and glucose
uptake in adipocytes. The expression of SIK2 (A),
CRTC2 (B) and HDAC4 (C) was reduced by
electroporation of siRNA into differentiated 3T3-L1
adipocytes, and GLUT4 protein levels were
analysed by western blotting 72 h after
electroporation. Silencing of the respective proteins
was confirmed by western blotting (supplementary
material Fig. S2). Bar graphs represent the
mean6s.e.m. of quantified western blot signals
from three or four individual experiments, in which
the data were normalized to those of Scr-treated
cells (set as 100%). (D) Adipocyte lysates from 28-
week-old male wild-type (wt) and SIK2-knockout
(ko) mice were analysed for GLUT4 protein levels
by western blotting. The bar graph represents the
mean6s.e.m. of quantified western blot signals
from three wild-type and two knockout mice. Similar
results were obtained when analyzing lysates
from adipocytes isolated and pooled from
11–21-week-old mice (seven per genotype, data
not shown). (E) Adenoviral vectors encoding GFP
or wild-type or Thr175Ala (T175A) HA–SIK2 were
introduced into primary rat adipocytes and basal
and insulin-stimulated (10 nM, 30 min) 14C glucose
uptake was measured. Data presented show the
mean6s.e.m. from six individual experiments, in
which the data were normalized to those of non-
treated GFP-expressing cells (set as 100%).
Primary rat adipocytes were treated with increasing
concentrations of the SIK inhibitors HG-9-91-01
(F–H) or MRT199665 (I) for 16 h, and 14C glucose
uptake was measured in the absence or presence
of insulin (10 nM, 30 min). Graphs represent the
mean6s.e.m. from three or four individual
experiments in which the data were normalized to
those of non-treated cells (F,I), cells treated without
inhibitor but with insulin (G) or cells treated without
insulin for each dose of the inhibitor (H).
*P,0.05; **P,0.01.
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Fig. 7. Regulation of SIK2 signalling
in human adipocytes. Primary
adipocytes isolated from human adipose
tissue were stimulated with isoprenaline
(100 nM, 30 min) (A–D,G,H) or treated
with HG-9-91-01 (1 mM, 16 h) (E,F). The
phosphorylation of SIK2 on residues
Ser343 (A), Ser358 (B) and Thr484 (C),
and the phosphorylation of CRTC2 on
Ser275 (E,G) and HDAC4 on Ser246
(F,H) was analyzed by western blotting
using phosphospecific antibodies. Bar
graphs represent the mean6s.e.m of
quantified western blot signals from two
(E,F), six (B), seven (C,G) or nine
(A,H) individual subjects, normalized to
total protein levels and expressed as a
percentage of signals from isoprenaline-
stimulated cells (A–C) or from non-
treated cells (E–H). Representative
immunoblots are shown. The
phosphorylation of HSL on Ser563 was
used as a positive control for the
stimulation with isoprenaline, and b-actin
was used as loading control. The kinase
activity of SIK2 (D) was measured by in
vitro kinase assay towards the peptide
substrate HDAC5tide. The bar graph
represents the mean6s.e.m of activity
data from six individual subjects.
P,0.05; **P,0.01; ***P,0.001.
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addition to Ser275, CRTC2 activity is controlled by
phosphorylation on Ser171 and Ser307 (Koo et al., 2005;
Screaton et al., 2004; Uebi et al., 2010). Owing to the lack of
commercially available tools of sufficient quality, we were not
able to confidently study the effect of SIK2 on these sites in
adipocytes. However, based on western blotting of lysates from
SIK2-siRNA-treated cells with the pCRTC3-Ser162-specific
antibody, which crossreacts with the corresponding Ser171 site
on CRTC2, it appears that Ser171 is also phosphorylated by
SIK2 in adipocytes. We attempted to directly map the sites
phosphorylated in CRTC2 when coexpressed with wild-type
SIK2 in primary adipocytes, but this analysis was hampered by
the poor yield of CRTC2 and a tryptic cleavage pattern generating
several peptides that were too large for detection.
In 3T3-L1 adipocytes expressing SIK2 siRNA, the phosphorylation
of CRTC2, CRTC3 and HDAC4 was comparable to the level
observed in Scr-siRNA-expressing cells stimulated with CL
316,243, which induced a dephosphorylation of all three proteins.
This suggests that SIK2 accounts for the portion of CRTC and
HDAC phosphorylation that is inhibited by cAMP. However, the
SIK3 isoform is also regulated by cAMP-induced phosphorylation
in adipocytes, resulting in reduced kinase activity (Berggreen et al.,
2012), and could potentially also phosphorylate CRTCs and class
IIa HDACs in adipocytes. Additional kinases involved in the
residual phosphorylation of CRTC2 and HDAC4 are still to be
determined, but might include MARK2, AMPK and/or SIK1.
However, AMPK is not likely to mediate cAMP effects
(dephosphorylation) on CRTCs and class IIa HDACs in
adipocytes, because AMPK in fact has been shown to be
activated by elevated cAMP levels in these cells (Omar et al., 2009).
It is assumed that PKA-dependent phosphorylation and
inhibition of SIK2 mediates the net dephosphorylation and
nuclear translocation of CRTCs and class IIa HDACs by cAMP;
however, activation of the cAMP–PKA pathway does not affect
the intrinsic kinase activity of SIK2 (Henriksson et al., 2012;
supplementary material Fig. S1). The identification of a direct
action of SIK2 on CRTCs and HDAC4 provided a read-out for
SIK2 cellular activity in adipocytes. This enabled us to perform a
series of experiments in order to address the functional
importance of the phosphorylation of SIK2 by PKA in these
cells. As we had shown previously in HEK293 cells (Henriksson
et al., 2012), phosphorylation of Ser358 was found to have a
much stronger impact on total PKA phosphorylation and 14-3-3
binding of SIK2 than any of the other PKA sites. Moreover, we
have also shown that Ser358 mediates a cAMP-induced
translocation of SIK2 to the cytosol in adipocytes (Henriksson
et al., 2012). Based on these data, we focused on the role of
Ser358 in the regulation of CRTCs and HDAC4 by cAMP.
Contrary to our expectations, expressing the cAMP-resistant
Ser358Ala SIK2 mutant did not prevent the dephosphorylation of
CRTC2 and HDAC4 in response to cAMP. The possibility
remains that the expression of the cAMP-insensitive SIK2 mutant
was not sufficient to mask the effect of endogenous SIK2, which
would still be responsive to cAMP. We therefore also tested the
effect of Ser358Ala SIK2 in our co-immunoprecipitation assay, in
which we found that wild-type SIK2 interacts with CRTCs and
HDAC4, and that the interaction with CRTCs (but not the one
with HDAC4) is reduced by cAMP. Although these results by
themselves suggest that the regulation of CRTC2 and CRTC3 by
cAMP indeed involves SIK2, this assay also provided an
opportunity to selectively analyse the effect of exogenous (HA-
tagged) SIK2 on CRTCs and HDAC4. Interestingly, mutation of
Ser358 to Ala prevented the cAMP-induced reduction in co-
immunoprecipitated CRTC2 or CRTC3 observed in wild-type
SIK2-expressing cells. Thus, our data suggest that Ser358 is
functionally important for some aspects of CRTC2 and CRTC3
regulation by cAMP, but not for that of HDAC4. Further studies
are required to fully understand the mechanism whereby CRTCs
and HDAC4 are activated in response to cAMP in adipocytes and
other cells, and the role of SIK2 herein. Individual or additional
PKA sites might, for example, have subtle effects on SIK2
function that we have so far not recognized, and mutating these
sites (possibly in combination) could be required to prevent the
regulation of CRTCs and HDAC4 by cAMP. In support of this,
we recently demonstrated that expression of a mutant form of
SIK2 in which all four PKA sites were substituted for an Ala
prevented the dephosphorylation of CRTC2, CRTC3 and HDAC4
in hepatocytes, but the mutation of the sites one by one did not
(Patel et al., 2014).
In our search for SIK2-interacting proteins, we also found that
subunits of PP2A co-immunoprecipitate with SIK2 in primary
adipocytes, and that the interaction was reduced in response to
cAMP induction. During the revision of our paper, it was reported
that SIK2 interacts with PP2A in HEK293T cells and that this is
functionally important to maintain both phosphatase and kinase
activities (Lee et al., 2014). Although the exact mechanisms
remain to be identified, the reduction of PP2A binding to SIK2
that we observed in response to cAMP–PKA activation could thus
be contributing to the inhibition of SIK2 function by cAMP
signalling.
Our identification of the transcriptional regulators CRTCs and
HDAC4 as molecular targets for SIK2 in adipocytes suggests that
SIK2 is involved in the regulation of gene transcription in
adipocytes. A previous report demonstrated that SIK2 inhibits
expression of the lipogenic genes ACC2 (also known as
ACACB), FASN and SCD1 in 3T3-L1 CAR adipocytes (Du
et al., 2008). However, the SIK2 substrate(s) mediating this effect
was not identified. Moreover, a potential link between these
genes and CRTCs and class IIa HDACs, as well as their
regulation by cAMP, has not been described to our knowledge.
Interestingly, a recent study proposed that regulation of class IIa
HDACs by cAMP influences the transcriptional regulation of
GLUT4 (Weems et al., 2012), implying a role for SIK2–HDAC4
in controlling glucose uptake in adipocytes. SIK2 could
potentially also regulate GLUT4 levels through its effects on
CRTCs, given that adipocyte CREB has been associated with the
transcription of GLUT4 through regulation of the repressor ATF3
(Qi et al., 2009). With this in mind, we focused our present
analysis of SIK2 function on GLUT4 expression and glucose
uptake. We indeed found that siRNA-mediated silencing or
genetic deletion of SIK2 (whole-body knockout) resulted in
reduced GLUT4 levels in adipocytes and that silencing of
HDAC4 or CRTC2 had the opposite effect. In relation to this,
overexpression of wild-type but not kinase inactive Thr175Ala
SIK2, was sufficient to enhance basal glucose uptake.
Conversely, two different inhibitors of SIK isoforms reduced
glucose uptake. Although the maximal level of glucose uptake in
the presence of insulin was also reduced after pre-treating cells
with SIK inhibitors, the fold induction by insulin was not
affected. Two studies have proposed that SIK2 negatively affects
insulin sensitivity in 3T3-L1 adipocytes and Mu¨ller cells of the
eye, by phosphorylating IRS1 on a serine residue (Ser789 and
Ser794 in murine IRS1 and human IRS1, respectively) (Horike
et al., 2003; Ku¨ser-Abali et al., 2013). However, we have
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previously failed to detect any phosphorylation of the
corresponding IRS1 peptide in vitro (Henriksson et al., 2012),
and our present results with regards to insulin-induced glucose
uptake also argue against any effects of SIK2 on insulin signalling
per se in adipocytes. In our experiments, the 16-h pre-treatment
with SIK inhibitors was followed by an incubation period of 2 h in
the absence of inhibitors. Any acute effects of SIK2 inhibition were
thus most likely reversed before the glucose uptake assay, and we
therefore suggest that the observed effects are due to changes in
gene expression. Taken together, our data are in line with the
hypothesis that SIK2 stimulates the rate of glucose uptake by
preventing HDAC4 and CRTC2 from inhibiting GLUT4
transcription. Future experiments should further evaluate this
hypothesis, for example, by investigating the direct requirement for
CRTC2 and HDAC4 in the regulation of glucose uptake by SIK2.
Another area to be explored is the potential role of SIK2 in
mediating hormonal effects on the expression of adipocyte genes,
for example GLUT4, which has been reported to be downregulated
by cAMP (Weems et al., 2012).
The main findings of this paper, and our hypothesis for how
these might be linked, are summarized in Fig. 8. In conclusion,
we present evidence that the transcriptional regulators CRTC2,
CRTC3 and HDAC4 are regulated by cAMP and are molecular
targets of SIK2 in adipocytes. We also show that PP2A interacts
with SIK2 in adipocytes and that this interaction is regulated by
cAMP. The phosphorylation of SIK2 by PKA might restrict SIK2
accessibility and/or binding to some of these targets (CRTC2,
CRTC3 and PP2A). This indicates that SIK2 could be involved in
controlling gene transcription in adipocytes, in particular those
affected by cAMP. Indeed, we found that GLUT4 mRNA and
protein levels, as well as glucose uptake, are stimulated
downstream of SIK2 in adipocytes.
MATERIALS AND METHODS
Materials
3T3-L1 cells were from American Type Culture Collection and DMEM,
FBS, gentamicin, dexamethasone, IBMX, insulin, isoprenaline, CL
316,243 and HA–agarose were all from Sigma. Protein-G–Sepharose
was from GE Healthcare. SuperScriptTMII RNaseH, DNase I, pre-cast
Novex SDS polyacrylamide Bis-Tris gels, Tris-acetate gels and LDS
sample buffer were all from Invitrogen. SuperSignal West Pico and
Femto Chemiluminescent Substrates were from Thermo Scientific.
RNeasyH Mini Kit and QIAzolTM lysis reagent were from Qiagen.
TaqmanH Gene Expression Assays for Stk11 (LKB1), Prkaa1
(AMPKa1), Sik2, Sik3, ribosomal protein S29 (Rps29) and 18S rRNA,
TaqmanH Universal PCR Master mix and SYBRH Green PCR Master
Mix were obtained from Applied Biosystems. The QuantiTect Primer
Assays with SYBRH Green detection for Glut4, Rps29 and 18s rRNA
were obtained from Qiagen. Penicillin-streptomycin was from VWR.
Complete protease inhibitor cocktail and phenylisopropyl adenosine
(PIA) were from Roche. [c32P]-ATP, 14C-glucose and 3H-2D-glucose
were from Perkin Elmer, and phosphocellulose P81 paper was from
Whatman. siRNAs were from Ambion. HDAC5tide was synthesised by
GL Biochem, China. Adenoviral vectors for GFP, human wild-type HA–
SIK2 (GenBank accession number XM_041314) and SIK2 mutants
Ser343Ala, Ser358Ala, Thr484Ala, Ser587Ala and Thr175Ala were
produced by Vector BioLabs Inc. HG-9-91-01 and MRT199665 were
kindly provided by Kristopher Clark and Philip Cohen (University of
Dundee, UK; Clark et al., 2012).
Antibodies
The following primary antibodies were used for western blotting: anti-
HSL-pSer563, anti-ERK1/2, anti-HDAC-4/5/7-pSer246/259/155, anti-
AMPK, anti-AMPK-pThr172, anti-CRTC3, anti-PP2A reg A (PR65,
detects both a- and b isoforms), anti-PP2A reg B (PR55, might detect a,
b, c and d isoforms) and consensus antibodies against phosphorylated
PKA substrates (PKA cons) were all from Cell Signaling Technology.
Anti-PP2A catalytic subunit (a isoform) was from Millipore. Anti-HA,
Fig. 8. Hypothesis for SIK2 action in adipocytes. In this
study, we have shown that CRTC2, CRTC3 and HDAC4
are direct molecular targets of SIK2 in adipocytes. Both
SIK2 and its substrates are subjected to regulation by
cAMP–PKA (Henriksson et al., 2012; and current data).
SIK2 is phosphorylated by PKA on multiple sites, out of
which Ser358 mediates 14-3-3 binding and cytosolic
translocation. By contrast, CRTC2, CRTC3 and HDAC4
are dephosphorylated in response to cAMP elevation and
this has, in other models, been shown to lead to nuclear
translocation. Our current data suggest that Ser358
phosphorylation might restrict the binding or accessibility
of SIK2 to its substrates and to PP2A, but further studies
are warranted in this area. Furthermore, we show that
GLUT4 expression is stimulated or inhibited downstream
of SIK2 or CRTC2–HDAC4, respectively. Finally, basal
glucose uptake is promoted by SIK2, potentially through its
effects on CRTC2, HDAC4 and GLUT4.
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anti-GAPDH and anti-b-actin were from Sigma, and anti-14-3-3 was
from Santa Cruz. Anti-CRTC2 was from Calbiochem and anti-HDAC4
and anti-LKB1 were from Abcam. The following antibodies were raised
in rabbit and affinity purified by Innovagen (Lund, Sweden); anti-
CRTC2-pSer275 (residues 268–282 of human CRTC2, AMNTGG
pSLPDLTNLH), anti-SIK2 (residues 906–926 of human SIK2,
LFDCEMLDAVDPQHNGYVLVN), anti-SIK2-pSer358 (residues 351–
365 of human SIK2, DGRQRRPpSTIAEQTV) and anti-SIK3 (residues
1349–1369 of human SIK3, TDILLSYKHPEVSFSMEQAGV). Anti-
GLUT4 antibodies were raised and purified as described previously
(Dawson et al., 2001). CRTC2 pSer275 was a kind gift from Robert
Screaton (University of Ottawa, Canada). The generation of anti-CRTC2
used for immunoprecipitation, anti-SIK2-pSer343 and anti-SIK2-
pThr484 antibodies was described previously (Patel et al., 2014). Anti-
CRTC3-pSer162 was a kind gift from Kristopher Clark and Philip Cohen
(University of Dundee, UK; Clark et al., 2012), and secondary antibodies
conjugated to horseradish peroxidase (HRP) were from Invitrogen (anti-
rabbit-IgG), Pierce (anti-sheep-IgG) and GE Healthcare (anti-mouse-IgG).
RNA preparation and quantitative real-time PCR
Analysis of gene expression was assessed by quantitative real-time PCR.
3T3-L1 adipocytes were lysed and homogenized in QIAzolTM lysis
reagent. Total RNA was isolated using the RNeasyH Mini Kit according
to the manufacturer’s recommendations. Total RNA (1 mg) was treated
with DNase I and then reverse transcribed using random hexamers
(Amersham Biosciences) and SuperScriptTMII RNaseH reverse
transcriptase according to the manufacturer’s recommendations. The
cDNA was used in quantitative PCR using TaqMan or SYBRHGreen
chemistry in an ABI 7900 Sequence Detection System. Relative
abundance of mRNA was calculated after normalization to the
geometric mean of two internal control genes (Rps29 and 18S rRNA)
(Ferguson et al., 2010; Vandesompele et al., 2002). Each sample was
analysed in duplicate.
Generation of a 3T3-L1 cell line with stable LKB1
shRNA expression
3T3L1 fibroblasts stably expressing scrambled or LKB1 shRNA were
generated by means of lentiviral transduction as described previously
(Gormand et al., 2014). Differentiation and preparation of cell lysates for
analysis by western blot was performed as described below.
Culture, differentiation, electroporation and stimulation of 3T3-
L1 adipocytes
3T3-L1 fibroblasts were cultured and differentiated as described
previously (Berggreen et al., 2009). All experiments were performed at
day 10–14 after differentiation. Between 85% and 95% of differentiated
cells were electroporated and/or stimulated with the b-adrenergic
receptor agonist CL 316,243. Cells were electroporated with 1–
1.5 nmole per 10-cm dish of either scrambled (Scr) siRNA (Ambion,
Neg control #1 siRNA) or siRNA targeting SIK2 (Ambion, ID s108118),
CRTC2 (Ambion, ID s92672) or HDAC4 (Ambion, ID s101930) using a
Bio-Rad Gene PulserTM with the following settings: 0.18 kV,
960 mFarad, resistance of ‘. 3T3-L1 adipocytes from one 10-cm dish
were plated onto two to three wells of a six-well plate following
electroporation and were stimulated as described above after 48–72 h of
gene silencing. After stimulation, cells were rinsed with PBS and harvested
in ice-cold lysis buffer containing 50 mM Tris-HCl pH 7.5, 1 mM EGTA,
1 mM EDTA, 1% (w/v) NP-40, 1 mM sodium orthovanadate, 10 mM
sodium-b-glycerophosphate, 50 mM sodium fluoride, 5 mM sodium
pyrophosphate, 0.27 M sucrose, 1 mM dithiothreitol (DTT) and complete
protease inhibitor (one tablet/50 ml). Following centrifugation at 4 C˚ for
15 min at 13,000 g, infranatants were collected and total protein content
was determined by Bradford.
Isolation, transduction and stimulation of primary adipocytes
Subcutaneous and/or omental adipose tissue was collected, after written
informed consent, from 11 patients (BMI 41610.3 kg/m2) undergoing
abdominal surgery. The human adipose tissue was placed in PBS at room
temperature and immediately transported to the laboratory for isolation.
Adipocytes were prepared from human adipose tissue or rat epididymal
adipose tissue as described previously under a protocol approved by the
ethical review committee at Lund University (number M286-10 for
animals and 2012/134 for humans) (Berggreen et al., 2009). After
isolation, human adipocytes were either stimulated directly with
isoprenaline in a 37 C˚ shaking water bath or incubated overnight with
HG-9-91-01 in DMEM containing penicillin and streptomycin (100 U/ml
and 0.1 mg/ml, respectively), 200 nM phenylisopropyl adenosine (PIA)
and 3.5% BSA at 37 C˚ under 5% CO2. Adipocytes were subsequently
washed and resuspended in KRH containing 1% BSA, defined in
Berggreen et al., 2009, and lysed in lysis buffer containing 50 mM Tris-
HCl pH 7.5, 0.27 M sucrose, 1 mM EDTA, 1 mM EGTA, 5 mM sodium
pyrophosphate, 1 mM sodium orthovanadate, 50 mM sodium fluoride,
1 mM DTT and complete protease inhibitor cocktail (one tablet/50 ml).
Lysates were centrifuged at 13,000 g for 15 min (4 C˚) and the
supernatant was collected. Rat adipocytes were transduced overnight
with adenoviruses encoding wild-type, Ser343Ala, Ser358Ala,
Thr484Ala, Ser587Ala or Thr175Ala HA–SIK2 (50–1506106 pfu/ml
cells; ,40–120 MOI) in DMEM containing 1 mg/ml gentamicin,
200 nM PIA and 3.5% BSA at 37 C˚ under 5% CO2. Adipocytes were
subsequently washed and resuspended in KRH and stimulated in a 37 C˚
shaking water bath, and lysates were prepared as described previously
(Berggreen et al., 2009). The transduction efficiency was ,90%, as
determined by transduction with GFP, and the fold overexpression when
using 1506106 pfu/ml cells was ,50-fold in terms of SIK2 kinase
activity level in wild-type SIK2-expressing cells compared to those
expressing GFP (data not shown).
SIK2 knockout mice
Whole-body SIK2 knockout mice were generated by crossing SIK2+/lox
mice described previously with deleter EIIa-CRE transgenic mice to
produce SIK2+/2 mice (Holzenberger et al., 2000; Patel et al., 2014). These
mice were crossed to generate wild-type (control) and SIK22/2 mice.
Routine genotyping was carried out by multiplex PCR on tail DNA with
the P1 (59-GTAGTTTACATTAGCACATTGGTGCCTC-39), P2 (59-
CCTAGAATGCACTCTGCAAACACTGGACAC-39) and P3 (59-
TCTACATGGAGGGTGTCGCAGAGCTCCATG-39) primers, to yield
amplification products of 391 bp (wild-type allele) with P1/P2 and 708 bp
(knockout allele) with P1/P3. Mice were bred (courtesy of Bente Kiens and
Erik Richter, University of Copenhagen) and sacrificed under a protocol
approved by the Danish Animal Experimental Inspectorate and that
complied with the European Convention for the Protection of Vertebrate
Animals used for Experiments and other Scientific Purposes (2010/63/
EU). Mice were housed in temperature-controlled (2261 C˚) facilities,
maintained on a 12:12 light:dark cycle and received standard chow
(Altromin, cat. no. 1324; Brogaarden, Lynge, Denmark) and water ad
libitum. Adipocytes were isolated from epididymal adipose tissue of male
28-week-old or 11–12-week-old mice, as described for rats (Berggreen
et al., 2009).
Measurement of SIK2 kinase activity
Cell lysates from 3T3-L1 or human adipocytes (25 or 10 mg of total
protein, respectively) were incubated for 1 h on a shaking platform with
5 mg of anti-SIK2 conjugated to 5 ml of packed Protein-G–Sepharose.
The immunoprecipitates were then further processed and the
phosphotransferase activity of immunoprecipitated SIK2 towards the
peptide substrate HDAC5tide (PLRKTASEPNLKRRR, residues 253–
267, R265, 266, 267 of human HDAC5) was measured as described
previously (Berggreen et al., 2009; Henriksson et al., 2012).
Immunoprecipitation and western blot analysis
Between 800 mg and 1200 mg of total protein from primary rat
adipocytes expressing HA-tagged SIK2 was pre-cleared using 5 ml of
packed Protein-G–Sepharose and then immunoprecipitated with 5 ml of
packed anti-HA–agarose and further processed as described above, with
the exception that co-immunoprecipitates were washed in the presence of
0.15 M NaCl (Berggreen et al., 2009). Alternatively, lysates (200 mg)
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were subjected to immunoprecipitation with 5 mg of anti-CRTC2
conjugated to 5 ml of packed Protein-G–Sepharose. Immunoprecipitates
or cell lysates (5–30 mg of total protein) were heated in LDS sample
buffer before loading onto pre-cast Novex 4–12% Bis-Tris or 7% Tris-
acetate gels. Tris-acetate gels were only used for the detection of
electrophoretic mobility shifts of CRTC2 and CRTC3 and were run at
100 V for 1.5 h. Proteins were then transferred to nitrocellulose
membrane as described previously (Berggreen et al., 2009). Detection
was performed using HRP-conjugated secondary antibodies, ECL reagent
and a Bio-Rad Chemidoc XRS+ system. Quantifications were made by
using the software Image Lab 4.0.
14C glucose uptake in rat adipocytes
Primary rat or mouse adipocytes were transduced with adenoviruses
encoding GFP, wild-type or Thr175Ala HA–SIK2 or, alternatively, were
treated with SIK inhibitors. Transductions and inhibitor treatments were
performed overnight in DMEM supplemented with gentamicin (1 mg/
ml), 3.5% BSA and PIA (200 nM), under 5% CO2 at 37 C˚, as described
above. Cells were then washed three times in a glucose-free incubation
buffer (pH 7.4) containing 30 mM HEPES, 0.12 M NaCl, 4 mM
KH2OPO4, 1 mM MgSO4, 0.75 mM CaCl2, 10 nM NaHCO3, 200 nM
adenosine and 1% BSA. A suspension of 5% cells was prepared in
triplicate and incubated for 1 h at 37 C˚ before the addition of insulin
(10 nM) and cytochalasin B (10 mM). Adipocytes were stimulated for
30 min followed by addition of 14C glucose (Perkin Elmer
NEC042x250UC, 2.5 ml/ml incubation buffer). The 14C glucose uptake
was stopped after 30 min by aliquoting 300 ml of the 400 ml adipocyte
suspension to Beckman microtubes containing 60 ml of dinonylphtalate
(DNP). The adipocyte suspension was centrifuged at 6000 g and frozen at
280 C˚ before the adipocytes were collected and subjected to scintillation
counting.
Generation of a stable HEK293 cell line expressing FLAG–SIK2
and large-scale purification of FLAG-SIK2
The generation and stimulation of HEK293 cells with stable inducible
expression of wild-type or Ser358Ala FLAG–SIK2 was performed using
the FlpInTM system as described previously (Henriksson et al., 2012).
HEK 293 cells expressing wild-type or Ser358Ala FLAG–SIK2 or vector
alone were harvested in lysis buffer containing 40 mM HEPES pH 7.4,
1% (w/v) Triton X-100, 1.5 mM sodium orthovanadate, 50 mM sodium
fluoride, 10 mM sodium pyrophosphate, 120 mM NaCl and complete
protease inhibitor (one tablet/50 ml). Lysates (50 mg of total protein)
were pre-cleared with protein-G–Sepharose for 1 h, and subsequently
incubated with 50 ml of packed anti-FLAG–agarose (Sigma) for 2 h.
The beads were washed twice with lysis buffer (defined above)
containing 0.5 M NaCl and twice with 10 mM Tris-HCl pH 7.5.
Immunoprecipitated proteins were then eluted by incubating for 1 h in
80 ml of 50 mM Tris-HCl pH 7.5, 150 mM NaCl and 200 mg/ml
36FLAG peptide (Sigma) at room temperature. After concentrating by
speed-vac, the eluates were loaded on a polyacrylamide gel, which was
subsequently stained with colloidal Coomassie Blue.
Mass fingerprinting
Protein bands were excised as shown in supplementary material Fig. S2
and incubated with 10 mM DTT at 37 C˚ for 20 min, followed by
treatment with 50 mM iodoacetamide at room temperature for 20 min in
the dark to alkylate Cys residues. After digestion with trypsin for 16 h,
the resultant peptides were analysed by mass spectrometric analysis (LC-
MS-MS) on a linear ion trap-orbitrap hybrid mass spectrometer
(Orbitrap-Classic, Thermo) equipped with a nanoelectrospray ion
source (Thermo) and coupled to a Proxeon EASY-nLC system.
Peptides were injected onto a Thermo (part number 160321) Acclaim
PepMap100 reverse phase C18 3-mm column, 75 mm615 cm, with a flow
rate of 300 nl/min. Peptides were eluted with a linear gradient of 95%
solvent A (2% acetonitrile, 0.1% formic acid in H2O) to 35% solvent B
(90% acetonitrile, 0.08% formic acid in H2O) at 20 min, followed by a
rise to 80% solvent B at 23 min, maintained at 80% solvent B for 5 min,
followed by re-equilibration. Data files were analysed using RAW2msm
(Matthias Mann, Max-Planck Institute) followed by Mascot searches
(www.matrixscience.com) against the SwissProt/Human Database of 25
April 2010.
Statistical methods
Results are presented as means6s.e.m., and analyses were performed
using Graph Pad Prism 5. The statistical significance of differences was
defined as *P,0.05, **P,0.01, ***P,0.001, and was determined using
a paired two-tailed Student’s t-test or, where appropriate, one-way
ANOVA followed by Holm Sidak’s multiple comparison test.
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